Obsidian Healthcare Group
The Obsidian Healthcare Group, founded in Melbourne in 1938 by Dr Alastair Prometheus Blackwood, grew into one of Australia's most powerful and least transparent private healthcare organisations. Across nearly nine decades, its operations expanded from a single wartime hospital to a national network of more than forty facilities. Its clinical outcomes were genuine. Its institutional culture was opaque. The relationship between the two defined the organisation's character and the questions that accompanied it.
Foundation
The Obsidian Healthcare Group was formally established in Melbourne in 1938 by Dr Alastair Prometheus Blackwood, a Hobart-born medical researcher whose career at the Walter and Eliza Hall Institute had produced both genuine innovation and persistent disquiet among his peers. Alastair was twenty-eight years old. The financial backing was quiet — believed to include foreign scientific societies and Australian landholding interests whose identities were never publicly confirmed — and the organisation's founding represented the institutional expression of a conviction that medicine's potential could be realised only through structures free from the constraints that university governance, hospital ethics committees, and public accountability imposed upon conventional research.
Obsidian's early motto — Observation before Intervention — reflected a philosophy in which data collection, behavioural analysis, and environmental control preceded and shaped clinical treatment. The motto's implications were broader than its clinical surface suggested, and the breadth became apparent only as the organisation's activities expanded into territories that the founding documents had not explicitly described.
The War Years and Early Expansion
Obsidian's first hospital, the Blackwood Memorial Hospital in Melbourne, opened in 1942 — a wartime facility that served both civilian and military patients. Its official purpose was trauma care and surgical rehabilitation. Its reputation for clinical excellence was genuine and was established rapidly. Internal documents from the 1950s, later partially declassified, suggested that the hospital's restricted upper floors housed research activities whose nature the facility's public function did not encompass, including the trialling of neurological techniques in collaboration with unnamed Defence affiliates.
In 1947, Obsidian acquired the Wellesley Estate on Hobart's eastern fringe and transformed it into Vaucluse Nursing Home. The facility's stated function as a residential aged care institution coexisted with an operational character that the stated function did not fully describe. Privately archived communications between Alastair and his Melbourne associates referred to the site's "strategic value," "operational privacy," and "controlled populations." The site's connection to Alastair's childhood geography — the island from which the Blackwood dynasty had originated — suggested motivations that exceeded commercial calculation, and the institution's activities during the 1950s and 1960s generated speculation that the absence of official confirmation did not extinguish.
The establishment of the Obsidian Clinic Network in 1950, beginning in regional Victoria and gradually expanding to urban sites in Adelaide, Canberra, and Launceston, marked Obsidian's transition from a private research initiative into a nationally recognisable healthcare provider. The clinics provided affordable primary care and preventive medicine to underserved populations. The public health outcomes were genuine. The data that the clinic network generated — demographic, medical, behavioural — flowed into systems whose analytical applications exceeded what the patients whose information it was could have understood or consented to.
Reputation and Controversy
The 1950s and 1960s brought expansion and the first sustained challenges to Obsidian's public reputation. Under Alastair's personal supervision, the organisation developed advanced surgical capabilities, particularly in reconstructive and neurosurgery, and maintained patient turnover rates whose speed reflected aggressive treatment protocols and early discharge practices. The quiet acquisition of failing independent clinics, often through legal mechanisms that left former owners bound by non-disclosure agreements, extended Obsidian's institutional reach with an efficiency that the acquired clinics' patients and staff sometimes experienced as absorption rather than partnership.
Rumours of unethical experimentation — particularly in aged care and psychiatric settings — began circulating through hospital staff and local media. A declassified 1963 government memo referred to "concerns about Obsidian's compliance with ethical research standards, particularly in dementia care and post-operative psychological conditioning." In 1968, journalist Patrick Crumley published a controversial exposé titled The Quiet Wing, which alleged that Obsidian's Grimshaw General Hospital housed a floor closed to both patients and families. Crumley was later discredited for unrelated misconduct, but his descriptions of patient "re-education suites" remained disturbingly specific.
Maxwell Blackwood's Tenure
Maxwell Alastair Blackwood, Alastair's son, assumed the Chief Executive role in 1971 following three decades of preparation — educated at Scotch College, the University of Melbourne, and the London School of Economics, and installed through the firm's operational hierarchy with the methodical precision his father applied to all institutional processes. Maxwell's tenure brought administrative modernisation and expanded the organisation's partnerships with universities, notably the University of Melbourne and Monash University, funding clinical research whose published endpoints sometimes differed from the confidential ones.
Maxwell died suddenly and without adequate explanation in Sydney on 3 May 1974, at the age of thirty-three. His death, whose circumstances the official record did not address with the thoroughness that the questions it generated required, removed from Obsidian the successor whose installation Alastair had spent three decades engineering. The proximity of Maxwell's death to the period of Alastair's most intensive private research — a proximity that might have been coincidental and that certain observers believed was not — added institutional crisis to the family's grief.
The Interregnum
The period between Maxwell's death in 1974 and the eventual appointment of Sebastian Charles Blackwood as Chief Executive in 2010 constituted thirty-six years of institutional management without family leadership. Alastair withdrew entirely into private research at his Daylesford estate following Maxwell's death, communicating with Obsidian's board through encrypted couriers and occasional dictation. He died on 30 September 1985, and his estate — including his personal research archives and coded journals — passed to the Obsidian Historical Trust, an internal entity exempt from public disclosure requirements.
During these decades, Obsidian's executive board managed the organisation's expansion under a succession of professional administrators whose names the public record preserved without generating the speculation that the Blackwood family's involvement had always attracted. The organisation's strategic direction continued along the lines that Alastair and Maxwell had established — clinical excellence as the public face, institutional opacity as the operational culture, and the quiet accumulation of facilities, data, and influence as the underlying programme.
In 1985, Dr Lena Khoury, a former pharmacological researcher at the Cromwell Specialist Clinic, accused Obsidian of cross-referencing patient biochemistry with behavioural trial results and of administering unapproved compounds under the guise of dietary supplements. Khoury disappeared later that year under circumstances officially attributed to personal travel. The accusation and the disappearance were neither confirmed nor resolved, and their juxtaposition entered the informal record that accompanied Obsidian's public reputation — the accumulation of incidents whose individual ambiguity did not prevent their collective effect from being substantial.
The organisation's facility portfolio expanded throughout the 1980s and 1990s: Grimshaw General Hospital in Adelaide, Greystone Manor in Canberra, Willowbrook Retirement Village in Queensland, Nightingale Medical Centre, and a network of rural clinics across South Australia and northern Tasmania. The acquisitions followed the established pattern — failing facilities absorbed through legal mechanisms, their records integrated into a centralised but inaccessible archival system referred to internally as Project Cassia. The project was believed to contain decades of anonymised but richly detailed human medical data, though its structure, legal status, and analytical applications remained undisclosed.
Alexander Blackwood's Consultancy
Dr Alexander Edward Blackwood, Alastair's nephew — the son of Alastair's brother Edward Thomas Blackwood — accepted a consultancy role with Obsidian in 2000. Alexander was a distinguished cardiologist whose professional reputation was independent of the organisation his uncle had founded. His decade-long association yielded mixed results: he successfully established satellite cardiac clinics in remote Queensland communities with Obsidian funding, but encountered resistance to proposals for complete fee transparency and public reporting of outcomes. His departure in 2009 reflected irreconcilable differences about whether healthcare was fundamentally a service or a commercial enterprise.
Sebastian Blackwood's Leadership
Sebastian Charles Blackwood, Alexander's son, assumed the Chief Executive role in 2010 following a period of internal restructuring. His appointment reconnected the Blackwood family to the organisation that his great-uncle Alastair had founded and that his father had briefly attempted to reform from a consultative position — a reconnection that came through the Edward branch of the family rather than the Alastair branch that had built and been consumed by the institution.
Sebastian brought to the role a medical background (University of Melbourne, Royal Melbourne Hospital) combined with healthcare administration credentials (University of New South Wales) whose systemic orientation suited an organisation whose institutional complexity required management capabilities that clinical training alone could not provide. His cousin Evelyn Rose Whitmore, née Blackwood — Maxwell's daughter, and thus a member of the Alastair branch — served as Director of Public Health Initiatives, her presence within the organisation adding a familial dimension whose significance those aware of Maxwell's death could not fail to register.
Under Sebastian's leadership, Obsidian pursued technological integration and strategic expansion. The Obsidian Research Initiative, launched in 2012, established collaborative platforms for medical research. The acquisition of the Cromwell Specialist Clinic in 2015 expanded the organisation's specialist services. Partnerships with the University of Melbourne and the Walter and Eliza Hall Institute of Medical Research facilitated research into neuroplasticity and age-related cognitive decline. The introduction of AI-driven patient care systems in 2019, including the proprietary ObsysTrack biometric and behavioural monitoring suite, represented the organisation's integration of surveillance technology into its clinical infrastructure — a development whose healthcare applications were genuine and whose broader implications reflected the founding philosophy that observation and intervention were aspects of the same enterprise.
The expansion into aged care services continued with the acquisition of Willowbrook Retirement Village in 2021 and further rural clinic development. A leaked internal memo from 2018 referred to the establishment of a "closed pilot cohort" designated Project Morrowfield, involving longitudinal observation of patients in palliative and post-traumatic states. The project's existence was never formally acknowledged by the organisation.
Institutional Culture
Obsidian's corporate culture became a subject of scrutiny independent of its clinical outcomes. Employees, including low-level clerical staff, signed binding non-disclosure agreements whose scope extended beyond employment. Psychological profiling was standard for mid-tier and senior positions. Performance reviews were conducted off-site. Staff turnover in the aged care division was the organisation's highest, yet exit interviews were never shared, even in aggregate. Internal policies included mandatory biometric identification systems for all staff and certain residents, integrity clauses that prevented whistleblowing even post-employment, and segmented departmental access that limited inter-role communication even within care settings.
Former employees, speaking anonymously, described a workplace characterised by surveillance awareness, the systematic isolation of dissenting voices, and unexplained internal transfers. Repeated FOI requests from independent researchers were denied on grounds of proprietary formats or cross-jurisdictional security restrictions. Families of deceased patients occasionally received follow-up contacts offering compensation packages whose terms discouraged legal action without explaining the basis for their provision.
The organisation's public reputation reflected the duality that had characterised it since its founding — clinical excellence whose genuineness was not seriously disputed, combined with institutional opacity whose depth was not seriously penetrated. The description that appeared in a 1996 editorial in The Age — "beyond accountability, but never entirely unlawful" — captured the assessment that Obsidian's observers had reached and that the organisation's subsequent decades of operation did nothing to revise.
Scale and Structure
By the mid-2020s, the Obsidian Healthcare Group operated more than forty facilities across Australia, with additional consultancy ventures in Singapore and New Zealand. Its revenue, privately held, was estimated at over three billion dollars annually. The Blackwood family retained full ownership through corporate structures whose complexity reflected the founder's conviction that institutional control and public accountability were, at a certain scale, incompatible objectives.
What began in 1938 as one man's attempt to reshape Australian medicine had become an institution operating at the intersection of healthcare, ethics, surveillance, and institutional self-perpetuation. Obsidian's clinical results were genuine. Its research contributions were measurable. Its institutional culture was opaque. And the question that had accompanied the organisation since its founding — whether its ultimate purpose was healing, observation, or something whose classification the available categories could not accommodate — persisted, unanswered, through the decades and the leadership transitions and the accumulation of facilities and data and influence, the question itself becoming, over time, the most durable thing the organisation had produced.






